Dexamethasone palmitate: A promising intratympanic treatment option for severe sudden hearing loss | Canada Hyperbarics Skip to main content
Case Report Am J Otolaryngol 2026

Dexamethasone palmitate: A promising intratympanic treatment option for severe sudden hearing loss

Ahn J — Am J Otolaryngol, 2026

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers treated three patients with sudden sensorineural hearing loss using intratympanic dexamethasone palmitate combined with HBOT, reporting outcomes in a small case series.

What They Found

All three patients showed hearing improvement following the combined treatment. The intratympanic route was well tolerated and may have enhanced local drug delivery compared to systemic steroids alone.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

Three patients is too small a sample to draw conclusions about efficacy or optimal treatment protocols.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 41406884
Year Published 2026
Journal Am J Otolaryngol
MeSH Terms Humans; Dexamethasone; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Hyperbaric Oxygenation; Injection, Intratympanic; Severity of Illness Index; Treatment Outcome

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology